Compare AbCellera Biologics Inc (ABCL) vs Consumer Staples Select Sector SPDR Fund (XLP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs Consumer Staples Select Sector SPDR Fund — how do they compare? AbCellera Biologics Inc trades at $8.92 (market cap $2.85B), while Consumer Staples Select Sector SPDR Fund trades at $84.65. The key difference: AbCellera Biologics Inc is trading nearer its 52-week high, Consumer Staples Select Sector SPDR Fund nearer its low. Which is the better fit depends on your goals.
| ABCL | XLP | |
|---|---|---|
Market Cap | $2.85B | — |
Sector | Health | — |
52-Week High | $9.76 | $90.00 |
52-Week Low | $2.78 | $75.61 |
Enterprise Value | $2.45B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
XLP trades at $85.12 with minimal daily movement (+0.01%). The ETF maintains a bullish technical outlook with strong moving average signals and oversold RSI conditions. Analyst consensus is unanimously positive with 100% buy ratings. Recent news highlights consumer staples sector resilience amid market uncertainty, with Coca-Cola's strong earnings demonstrating the defensive appeal of staple goods companies.
The defensive nature of consumer staples provides stability during market volatility, though limited financial ratio data requires deeper fundamental analysis. Key risks include sector rotation away from defensive plays and macroeconomic pressures on consumer spending. The 2.6% dividend yield offers income appeal for risk-averse investors seeking market exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Consumer Staples Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies that have been identified as Consumer Staples companies by the GICS®. It is non-diversified.
Read more on XLP →
